2022 · Saitoh — Molecular hydrogen suppresses Porphyromonas gingivalis lipopolysaccharide-induced increases in interleukin-1 alpha and interleukin-6 secretion in human gingival cells.
Super-Abstract
In a laboratory cell model of periodontitis, molecular hydrogen (H₂) significantly reduced the secretion of two key inflammatory cytokines — IL-1α and IL-6 — triggered by a major periodontal pathogen. The effect was achieved without harming the cells themselves. This is a cell-culture study; no clinical conclusions about humans with periodontitis can be drawn from it. (Molecular and Cellular Biochemistry, 2022.)
Commentary
Periodontitis is driven by a vicious cycle of bacterial infection and exaggerated immune response. Porphyromonas gingivalis and its lipopolysaccharide (LPS) are well-established initiators of this inflammatory cascade. Saitoh et al. used human gingival cells exposed to Pg-LPS and tested whether dissolved H₂ could dampen the resulting cytokine storm. Out of eight inflammatory markers measured, two — IL-1α and IL-6 — were significantly elevated by Pg-LPS and then meaningfully suppressed by H₂ without cytotoxicity. The other six markers were not significantly altered. The mechanism proposed is H₂ acting as a selective antioxidant that reduces oxidative stress in the gingival microenvironment. The study is well-designed at the in-vitro level, but the gap from cell culture to clinical reality in a living periodontal pocket is large. Whether dissolved H₂ can reach sufficient concentrations in vivo at the site of infection remains an open question.
Key quotes
- „H2 significantly suppressed the secretion of both cytokines without cytotoxicity.“ — core finding: IL-1α and IL-6 reduced, cells unharmed
- „no human periodontitis model has examined the anti-inflammatory effects of H2“ — authors acknowledge this is the first study of its kind — a gap in the evidence base
- „H2 may provide therapeutic applications for periodontitis.“ — cautious, speculative conclusion by the authors — not a clinical claim
Our assessment
An interesting in-vitro pilot signal for H₂ in the context of oral inflammation. This is a cell-culture study (in vitro), not a human trial — results are exploratory and cannot be directly transferred to clinical practice. Only two of eight cytokines were significantly affected; the breadth of the anti-inflammatory effect remains limited in this model. The study is a useful first step that motivates further research, but has no direct therapeutic implications for patients with periodontitis at this stage.
Study design
- Type: in-vitro experiment · Model: human gingival cells, Pg-LPS stimulation · H₂ delivery: unspecified (dissolved H₂ in medium)
- Outcome: IL-1α and IL-6 secretion significantly suppressed by H₂; no cytotoxicity observed; 6 of 8 inflammation markers not significantly changed
Abstract
Periodontitis is defined as a multifactorial polymicrobial infection accompanied by inflammatory reactions. Porphyromonas gingivalis (Pg) is known as a major pathogen in the initiation and progression of periodontitis, and a major virulence factor is Pg lipopolysaccharide (LPS). Molecular hydrogen (H2) has been reported to act as a gaseous antioxidant, which suppresses periodontitis progression by decreasing gingival oxidative stress. However, no human periodontitis model has examined the anti-inflammatory effects of H2. In this study, we examined the effects of H2 on Pg LPS-induced secretion of 8 types of inflammation markers in a human periodontitis model using human gingival cells with enzyme-linked immunosorbent assays. Our results demonstrated that Pg LPS increased interleukin (IL) 1 alpha (IL-1α) and IL-6 secretion, but H2 significantly suppressed the secretion of both cytokines without cytotoxicity. H2 can suppress the production of IL-1α and IL-6, which are identified as cytokines involved in inflammatory reactions in periodontal disease. Thus, H2 may provide therapeutic applications for periodontitis.
Source & links
Screenshot of the PubMed page
This page mirrors the published abstract (© the authors / publisher) for reference and citation. The canonical source is the PubMed record linked above. This is not medical advice.